|
|
Volumn 59, Issue SUPPL., 2002, Pages
|
|
Identification of cancer patients at high risk of febrile neutropenia
|
|
Author keywords
Age; Antineoplastic agents; Combined therapy; Diagnosis; Flourouracil; Neoplasms; Neutropenia; Radiation; Toxicity
|
|
Indexed keywords
ALBUMIN;
BLEOMYCIN;
COLONY STIMULATING FACTOR;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EPIRUBICIN;
ETOPOSIDE;
FLUOROURACIL;
LACTATE DEHYDROGENASE;
MITOXANTRONE;
NAVELBINE;
PREDNISONE;
RECOMBINANT ERYTHROPOIETIN;
THYMINE;
VINCRISTINE;
ANTINEOPLASTIC AGENT;
ALBUMIN BLOOD LEVEL;
BONE MARROW CELL;
BONE MARROW SUPPRESSION;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CONFERENCE PAPER;
COST EFFECTIVENESS ANALYSIS;
COST MINIMIZATION ANALYSIS;
DIARRHEA;
DISEASE ASSOCIATION;
ELDERLY CARE;
ENZYME ASSAY;
FEBRILE NEUTROPENIA;
HIGH RISK PATIENT;
HUMAN;
HYPOTENSION;
LUNG CANCER;
MAJOR CLINICAL STUDY;
NEUTROPENIA;
NONHODGKIN LYMPHOMA;
OUTPATIENT;
PATIENT SELECTION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RECURRENT DISEASE;
RISK FACTOR;
AGED;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
LUNG TUMOR;
MIDDLE AGED;
REVIEW;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CLINICAL TRIALS;
HUMANS;
LUNG NEOPLASMS;
LYMPHOMA, NON-HODGKIN;
MIDDLE AGED;
NEUTROPENIA;
RISK FACTORS;
|
|
EID: 0036684578
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.1093/ajhp/59.suppl_4.s16 Document Type: Conference Paper |
|
Times cited : (16)
|
|
References (13)
|
